Literature DB >> 17655583

Nonleukoreduced red blood cell transfusion induces a sustained inhibition of neutrophil chemotaxis by stimulating in vivo production of transforming growth factor-beta1 by neutrophils: role of the immunoglobulinlike transcript 1, sFasL, and sHLA-I.

Luciano Ottonello1, Massimo Ghio, Paola Contini, Maria Bertolotto, Giordano Bianchi, Fabrizio Montecucco, Marco Colonna, Clemente Mazzei, Franco Dallegri, Franco Indiveri.   

Abstract

BACKGROUND: Red blood cell (RBC) transfusion has been linked to increased susceptibility to infections in critically ill patients and to augmented incidence of postoperative infections. The mechanisms by which transfusions can induce immunosuppression are only partially defined. Recently, it has been demonstrated that RBC supernatants inhibit neutrophil migration. Such inhibitory activity is due to transforming growth factor (TGF)-beta1 contained in the supernatants that desensitize neutrophils to subsequent chemotaxic stimulation. STUDY DESIGN AND METHODS: In ancillary experiments, it was observed that plasma from transfused patients maintained its capacity of inhibiting neutrophil chemotaxis several days after RBC transfusion. Thus, this study was planned to investigate the mechanism(s) responsible for the prolonged inhibition of neutrophil chemotaxis observed after RBC transfusion.
RESULTS: Plasma samples obtained from subjects who underwent RBC transfusion display a capability of inhibiting neutrophil chemotaxis, which is detectable up to 15 days after the transfusion. The inhibition is related to the capacity of FasL and HLA-I molecules contained in RBC supernatants to induce in vivo TGF-beta1 synthesis by neutrophils. The induction of TGF-beta1 secretion in neutrophils by HLA-I molecules depends on immunoglobulinlike transcript 1/CD85 triggering.
CONCLUSION: The property of RBC transfusion of inducing a sustained inhibition of neutrophil chemotaxis seems to be a potential mechanism that concurs to the susceptibility to infections in patients who receive transfusions. Furthermore, our findings, showing neutrophil production of TGF-beta1 in response to FasL and HLA-I molecules, confirm that neutrophils are endowed not only with effector functions but also with immunomodulatory properties possibly involved in the regulation of inflammatory processes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17655583     DOI: 10.1111/j.1537-2995.2007.01268.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  9 in total

1.  sHLA-I Contamination, a novel mechanism to explain ex vivo/in vitro modulation of IL-10 synthesis and release in CD8(+) T lymphocytes and in neutrophils following intravenous immunoglobulin infusion.

Authors:  Massimo Ghio; Paola Contini; Maurizio Setti; Gianluca Ubezio; Clemente Mazzei; Gino Tripodi
Journal:  J Clin Immunol       Date:  2010-02-02       Impact factor: 8.317

2.  Bio-modulators in platelet-rich plasma: a comparison of the amounts in products from healthy donors and patients produced with three different techniques.

Authors:  Gianluca Ubezio; Massimo Ghio; Paola Contini; Roberta Bertorello; Gennaro Marino; Andrea Tomasini; Gino Tripodi
Journal:  Blood Transfus       Date:  2013-01-23       Impact factor: 3.443

3.  Donor neutrophil activation and transforming growth factor-β1 modulation induced by donor apheresis procedures.

Authors:  Massimo Ghio; Paola Contini; Filippo Ansaldi; Gianluca Ubezio; Maurizio Setti; Marco Risso; Gino Tripodi
Journal:  Blood Transfus       Date:  2014-10       Impact factor: 3.443

4.  Blood transfusions with high levels of contaminating soluble HLA-I correlate with levels of soluble CD8 in recipients' plasma; a new control factor in soluble HLA-I-mediated transfusion-modulated immunomodulation?

Authors:  Massimo Ghio; Paola Contini; Gianluca Ubezio; Filippo Ansaldi; Maurizio Setti; Gino Tripodi
Journal:  Blood Transfus       Date:  2012-12-21       Impact factor: 3.443

Review 5.  Mechanisms of red blood cell transfusion-related immunomodulation.

Authors:  Kenneth E Remy; Mark W Hall; Jill Cholette; Nicole P Juffermans; Kathleen Nicol; Allan Doctor; Neil Blumberg; Philip C Spinella; Philip J Norris; Mary K Dahmer; Jennifer A Muszynski
Journal:  Transfusion       Date:  2018-01-30       Impact factor: 3.157

Review 6.  Regulation of T-cell immunity by leucocyte immunoglobulin-like receptors: innate immune receptors for self on antigen-presenting cells.

Authors:  Katie J Anderson; Rachel L Allen
Journal:  Immunology       Date:  2009-05       Impact factor: 7.397

Review 7.  Transfusion-related immunomodulation: review of the literature and implications for pediatric critical illness.

Authors:  Jennifer A Muszynski; Philip C Spinella; Jill M Cholette; Jason P Acker; Mark W Hall; Nicole P Juffermans; Daniel P Kelly; Neil Blumberg; Kathleen Nicol; Jennifer Liedel; Allan Doctor; Kenneth E Remy; Marisa Tucci; Jacques Lacroix; Philip J Norris
Journal:  Transfusion       Date:  2016-10-02       Impact factor: 3.157

8.  PRBC-derived plasma induces non-muscle myosin type IIA-mediated neutrophil migration and morphologic change.

Authors:  Chen Yu; Li Xu; Lii-fang Chen; Ying-jie Guan; Minsoo Kim; Walter L Biffl; Y Eugene Chin
Journal:  Immunopharmacol Immunotoxicol       Date:  2012-10-19       Impact factor: 2.730

Review 9.  Leukocyte Ig-Like Receptors - A Model for MHC Class I Disease Associations.

Authors:  Laura Emily Hudson; Rachel Louise Allen
Journal:  Front Immunol       Date:  2016-07-25       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.